The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
- PMID: 24985890
- PMCID: PMC4282596
- DOI: 10.1007/s00213-014-3658-3
The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
Abstract
Rationale: Serotonin 5-HT2A and 5-HT2C receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic drugs, but recently there has been interest in metabotropic glutamate (mGluR2) receptors as contributors to the mechanism of hallucinogens.
Objective: The present study assesses the role of these 5-HT and glutamate receptors as molecular targets for two tryptamine hallucinogens, N,N-dimethyltryptamine (DMT) and N,N-diisopropyltryptamine (DiPT).
Methods: Drug discrimination, head twitch, and radioligand binding assays were used. A 5-HT2AR inverse agonist (MDL100907), 5-HT2CR antagonist (SB242084), and mGluR2/3 agonist (LY379268) were tested for their ability to attenuate the discriminative stimulus effects of DMT and DiPT; an mGluR2/3 antagonist (LY341495) was tested for potentiation. MDL100907 was used to attenuate head twitches induced by DMT and DiPT. Radioligand binding studies and inosital-1-phosphate (IP-1) accumulation were performed at the 5-HT2CR for DiPT.
Results: MDL100907 fully blocked the discriminative stimulus effects of DMT, but only partially blocked DiPT. SB242084 partially attenuated the discriminative stimulus effects of DiPT, but produced minimal attenuation of DMT's effects. LY379268 produced potent, but only partial blockade of the discriminative stimulus effects of DMT. LY341495 facilitated DMT- and DiPT-like effects. Both compounds elicited head twitches (DiPT>DMT) which were blocked by MDL1000907. DiPT was a low-potency full agonist at 5-HT2CR in vitro.
Conclusions: The 5-HT2AR likely plays a major role in mediating the effects of both compounds. 5-HT2C and mGluR2 receptors likely modulate the discriminative stimulus effects of both compounds to some degree.
Figures





Similar articles
-
Discriminative stimulus effects of N,N-diisopropyltryptamine.Psychopharmacology (Berl). 2013 Mar;226(2):241-6. doi: 10.1007/s00213-012-2891-x. Epub 2012 Oct 16. Psychopharmacology (Berl). 2013. PMID: 23070023 Free PMC article.
-
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.Pharmacol Biochem Behav. 1998 Nov;61(3):323-30. doi: 10.1016/s0091-3057(98)00110-5. Pharmacol Biochem Behav. 1998. PMID: 9768567
-
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.Pharmacol Biochem Behav. 2006 Jan;83(1):122-9. doi: 10.1016/j.pbb.2005.12.015. Epub 2006 Feb 3. Pharmacol Biochem Behav. 2006. PMID: 16460788
-
The hallucinogenic world of tryptamines: an updated review.Arch Toxicol. 2015 Aug;89(8):1151-73. doi: 10.1007/s00204-015-1513-x. Epub 2015 Apr 16. Arch Toxicol. 2015. PMID: 25877327 Review.
-
Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.Phytochemistry. 2024 Feb;218:113928. doi: 10.1016/j.phytochem.2023.113928. Epub 2023 Nov 29. Phytochemistry. 2024. PMID: 38035973 Review.
Cited by
-
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.Transl Psychiatry. 2020 Sep 28;10(1):331. doi: 10.1038/s41398-020-01011-0. Transl Psychiatry. 2020. PMID: 32989216 Free PMC article.
-
Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17. Psychopharmacology (Berl). 2019. PMID: 30448990 Free PMC article.
-
Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Front Psychiatry. 2017 Aug 18;8:152. doi: 10.3389/fpsyt.2017.00152. eCollection 2017. Front Psychiatry. 2017. PMID: 28868040 Free PMC article. Review.
-
Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711. doi: 10.1093/ijnp/pyx036. Int J Neuropsychopharmacol. 2017. PMID: 28525587 Free PMC article.
-
Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs.J Psychopharmacol. 2025 Jul;39(7):629-651. doi: 10.1177/02698811251330780. Epub 2025 Apr 17. J Psychopharmacol. 2025. PMID: 40243002 Free PMC article. Review.
References
-
- Appel JB, West WB, Rolandi WG, Alici T, Pechersky K. Increasing the selectivity of drug discrimination procedures. Pharmacology Biochemistry and Behavior. 1999;64:353–358. - PubMed
-
- Cartmell J, Monn JA, Schoepp DD. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther. 1999;291:161–70. - PubMed
-
- Delille HK, Becker JM, Burkhardt S, Bleher B, Terstappen GC, Schmidt M, Meyer AH, Unger L, Marek GJ, Mezler M. Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades. Neuropharmacology. 2012;62:2184–91. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources